"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...
(Generic versions may still be available.)
|1.||Acute herpes simplex, vaccinia, varicella and other viral diseases of the cornea and conjunctiva, viral otic infections|
|2.||Tuberculosis, Mycobacterial infection of the eye.|
|3.||Fungal diseases of ocular and auricular structures.|
|4.||Acute purulent infections (may be masked or enhanced by the presence of the steroid.)|
|5.||Hypersensitivity to any of the components of the medicines.|
|6.||Mechanical lacerations and abrasions of the eye.|
|7.||Perforation of the eardrum.|
|8.||Opthalmic use of these combinations is always contraindicated after uncomplicated removal of a corneal foreign body.|
Last reviewed on RxList: 2/15/2005
This monograph has been modified to include the generic and brand name in many instances.
Additional Terra-Cortril Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.